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Abstract
Isogenic cells sensing identical external signals can take markedly different decisions. Such decisions often correlate with
pre-existing cell-to-cell differences in protein levels. When not neglected in signal transduction models, these differences are
accounted for in a static manner, by assuming randomly distributed initial protein levels. However, this approach ignores
the a priori non-trivial interplay between signal transduction and the source of this cell-to-cell variability: temporal
fluctuations of protein levels in individual cells, driven by noisy synthesis and degradation. Thus, modeling protein
fluctuations, rather than their consequences on the initial population heterogeneity, would set the quantitative analysis of
signal transduction on firmer grounds. Adopting this dynamical view on cell-to-cell differences amounts to recast extrinsic
variability into intrinsic noise. Here, we propose a generic approach to merge, in a systematic and principled manner, signal
transduction models with stochastic protein turnover models. When applied to an established kinetic model of TRAIL-
induced apoptosis, our approach markedly increased model prediction capabilities. One obtains a mechanistic explanation
of yet-unexplained observations on fractional killing and non-trivial robust predictions of the temporal evolution of cell
resistance to TRAIL in HeLa cells. Our results provide an alternative explanation to survival via induction of survival pathways
since no TRAIL-induced regulations are needed and suggest that short-lived anti-apoptotic protein Mcl1 exhibit large and
rare fluctuations. More generally, our results highlight the importance of accounting for stochastic protein turnover to
quantitatively understand signal transduction over extended durations, and imply that fluctuations of short-lived proteins
deserve particular attention.
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Introduction
TNF-Related Apoptosis Inducing-Ligand (TRAIL) is a prom-
ising therapeutic agent against cancer because it induces apoptosis
specifically in tumor cells [1–3]. This motivated dozens of clinical
trials based on TRAIL-related therapies. However, efficiency was
usually limited [4]. Most of the molecular events leading from
TRAIL exposure to cell death are known [3]. After TRAIL
binding to death receptors, initiator caspases are activated, which
in turn promote effector caspases activation either directly or via a
mitochondrial pathway (Fig. S1). In most cells, Mitochondrial
Outer Membrane Permeabilization (MOMP) is required to
efficiently activate effector caspases. Several kinetic models have
been proposed to describe a part or all of those biochemical
reactions [5–12].
Not all cells of an isogenic population die after TRAIL
treatment, even at saturating ligand doses. This fractional killing
property is widely shared among cell lines and is critical for
therapeutical applications [13]. In addition, surviving cells were
shown to be transiently resistant to a second TRAIL treatment.
This reversible resistance property was observed in various cell
lines and could also have important implications for therapy
[14,15]. Fractional killing is generally thought to result from cross
talks between the apoptosis pathway and survival pathways [16].
Indeed, several studies reported that TRAIL increases the
production of anti-apoptotic proteins, via the activation of survival
pathways [17–19]. While fractional killing illustrates cell-to-cell
variability in the decision between life and death, variability is also
observed among cells that die: they commit to death after a highly
variable delay from one another [13,20]. This variability cannot
be explained by differences in TRAIL-induced gene regulation: it
is also observed when cells are co-treated with cycloheximide
(CHX), an efficient inhibitor of protein synthesis [13]. Rather, it
was proposed to originate mostly from pre-existing differences in
the levels of proteins composing the apoptosis pathway. Indeed,
recently divided sister cells die almost synchronously [13,20], as
expected if protein content is equally shared between daughters
and if noise in signaling reactions play a marginal role. This
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explanation was supported by modeling: when taken as initial
conditions of a deterministic, kinetic model describing signaling
reactions, differences in protein levels are sufficient to explain
observed variability in death times [13].
Another observation indicated that this cell-to-cell variability in
protein levels is not frozen but result from a dynamical equilibrium
driven by fluctuations in individual cells: death synchrony between
sister cells was weaker as the duration between division and
treatment increased [13,20]. To quantitatively assess this effect, the
previously mentioned modeling approach, where only the conse-
quences of protein fluctuations (cell-to-cell variability at a fixed time)
are accounted, is inadequate. Instead, protein fluctuations them-
selves should be modeled. The need to account for protein
fluctuations is even more stringent when considering observations
after treatment with TRAIL alone. In that case, protein synthesis is
not blocked and thus can impact the decision between life and
death. Even if TRAIL does not change protein synthesis (via
induction of survival pathways), significant differences with TRAIL
and CHX treatments are expected, as the constitutively noisy
protein synthesis will interact with signaling reactions. Thus, before
complexifying the model to account for eventual regulations via
survival pathways induction, it is critical to assess how much can be
explained when protein synthesis is not altered by TRAIL signaling.
Here, we investigate this question by enabling a kinetic model of
TRAIL-induced apoptosis with stochastic protein turnover for all
proteins, following a generic and principled approach. To our
knowledge, this is the first attempt to systematically include gene
expression noise in a signal transduction model. It enriches the
model with a fundamental property as the dynamics of cell-to-cell
variability is represented, allowing disentangling the effects of
constitutive protein fluctuations, signaling protein-protein reactions
and potentially induced changes in protein synthesis.
Results
Extended vision of signal transduction pathways
Protein synthesis and degradation are subjected to noise, resulting
in fluctuations of protein concentrations in individual cells and in
cell-to-cell variability at the population level [21,22]. Such
variability could have consequences on signal transduction: aside
of conventional epigenetic differences [23], unequal access to ligand
molecules or simply noise in signaling reactions, it often contributes
importantly to heterogeneous behavior within an isogenic popula-
tion [13,24]. One approach to account for those differences is to
incorporate protein level variability as random initial conditions of
an ODE model describing the signaling reactions (‘‘extrinsic noise
approach’’) [13,25]. However, variability is imposed at time zero
and then behavior is deterministic: it is thus not appropriate to study
transduction on long time scales, during which protein levels
dynamically fluctuate [26]. A more natural manner to account for
protein level variability is to represent their stochastic synthesis and
degradation (‘‘intrinsic noise approach’’). Although several studies
did account for cell-to-cell differences in protein levels in an
extrinsic, static manner via random initial conditions [13,27,28],
and many models of signal transduction considered the effect of
noise in protein-protein reactions [29,30] or in the expression of
signal transduction target genes [31–33], no kinetic model of signal
transduction pathways considering systematically noise in protein
synthesis and degradation has been developed so far. Here by
systematically we mean for all the proteins acting in the pathway.
We propose a modeling approach to account for gene
expression noise within kinetic models of signal transduction
pathways. Following Singh et al. [34], we model protein turnover
with stochastic processes describing mRNA level fluctuations, and
deterministic processes for protein translation and degradation
(random telegraph model, see also [35–41]). These processes are
integrated into a kinetic model of protein-protein reactions
(Fig. 1). While the rates of such stochastic protein turnover models
(Fig. 2A) are rarely directly measurable, their value can be
constrained by using experimentally measurable data and
analytical results (Fig. S2). Recently, significant progress has been
made on both experimental and theoretical sides to enable this
inference approach [34–41]. Importantly, we found that for
typical protein and mRNA half-lives, a large set of promoter rate
combinations lead to similar fluctuations at the protein level, as
characterized by protein level variability (coefficient of variation)
and mixing time (half-autocorrelation time). Interestingly, the
obtained mixing time is around 40 hours (Fig. 2B), in the middle
of the range of experimentally estimated values for twenty
endogenous proteins in human cells [26]. Thus, standard
stochastic protein turnover models (Fig. 2C) can provide a good
approximation of protein fluctuations for most proteins. Only
short-lived proteins necessitate particular attention (Fig. S3). This
finding is a cornerstone of our approach.
Modeling stochastic protein turnover in TRAIL-induced
apoptosis
We applied this approach to TRAIL-induced apoptosis, using
EARM kinetic model [5,13] to describe protein-protein reactions
taking place between TRAIL exposure and cell death commit-
ment. We equipped all native proteins with a default model of
stochastic protein turnover, with the exception of proteins with fast
turnover, here Flip and Mcl1 [42–44]. Details of model
construction are given in Text S1 (see dedicated section, Fig. S4
and Tables S1-3). Importantly, all parameters have been
constrained based on experimental data and analytical results,
with the exception of four parameters (‘‘ON’’ and ‘‘OFF’’
promoter switching rates, mRNA and protein half-lives for Flip
and Mcl1). Note that because of their similar protein and mRNA
half-life, we use the same couple of promoter switching rates for
both proteins in our exploration of parameter space. This
drastically limited the number of introduced degrees of freedom
and made it possible to systematically explore realistic ranges for
remaining parameters. To study the influence of stochastic protein
turnover on fractional killing and reversible resistance, we sought
to confront our model with existing quantitative data about
TRAIL-induced apoptosis in HeLa cells. Those experiments,
described in detail later, can be classified into two groups based on
the type of information they contain: 1) quantification of the
variability in cell fate, 2) characterization of the transient memory
Author Summary
TRAIL induces apoptosis selectively in cancer cells and is
currently tested in clinics. Having a mechanistic under-
standing of TRAIL resistance could help to limit its
apparition. Several observations suggested that protein
level fluctuations play an important role in TRAIL resistance
and its acquisition. However, quantitative, systems-level
approaches to investigate their role in cellular decision-
making processes are lacking. We propose a generic and
principled approach to extend signal transduction models
with protein fluctuation models for all proteins in the
pathway. The key aspect is to use standard protein
fluctuation models for long-lived proteins. We show that
its application to TRAIL-induced apoptosis provide a
quantitative, mechanistic explanation to previously pub-
lished but yet unexplained critical observations.
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in cell state. While previous approaches using ODE models with
distributions for initial protein levels (capturing a static description
of cell-to-cell variability) [13,25] are potentially able to reproduce
the first type of data, a dynamic view on cell-to-cell variability as
proposed in our model is needed to account for both types of data.
We adopted the following strategy: first, search for models able to
reproduce observations on cell fate variability; and second test
whether valid models can robustly predict observed behaviors
where transient memory matters.
Stochastic protein turnover models predict transient
memory in cell sensitivity to TRAIL and CHX
Using live-cell microscopy, Spencer et al. [13] investigated the
fate of hundreds of cells after exposure to TRAIL and CHX
(10 ng/mL and 2.5 mg/mL, Fig. 3A). All cells undergo MOMP
with a highly variable delay (from 2 to 8 hours, Fig. 3B). To study
cell fate inheritance, the authors also recorded 20 hours before
treatment to identify sister cells (Fig. 4A). They were found to have
highly correlated MOMP times (correlation coefficient close to 1
for recently divided cells, about 0.5 for older sisters - Fig. 4B, black
curve). Here, the MOMP time distribution provides a quantifica-
tion of the cell fate variability, while MOMP time correlations
between sister cells also give information on the transient memory
in cell state. Within our framework, in-silico reproduction of those
experiments is straightforward (Figs. 3D and 4C), enabling us to
investigate possible origins of transient cell fate inheritance. We first
asked if the observed cell fate variability could be reproduced. In the
model, it is only determined by protein levels at treatment time
(behavior is deterministic as synthesis is assumed to be fully blocked
by CHX and noise in signaling reactions is neglected), and
differences between sister cells are only caused by protein synthesis
noise occurring between division and treatment (in agreement with
the fact that recently divided sisters died almost synchronously, we
assumed an equal repartition of protein content at division). We
found that excellent agreement with observed MOMP time
variability can be obtained (Fig. 3E). Further analysis revealed that
such agreement requires Flip and Mcl1 protein half-life to be short
and to fall within a narrow range (between 0.3 and 0.6 hours, Fig.
S5-C). This model prediction is consistent with previous measure-
ments in HeLa cells (30 and 40 minutes for Flip short isoform and
Mcl1 respectively, [42,43]). In contrast, Flip and Mcl1 mRNA half-
life and promoter switching rates are not strongly constrained,
probably because their influence on cell fate is limited by the rapid
protein level decrease caused by synthesis blockade. We then asked
whether our extended model also capture transient cell fate
inheritance (Fig. 4B). It is the case: fitted models accurately predict
the MOMP time correlation between sister cells (Fig. 4D - black
curve, Fig. S5-C). Of note, assuming standard promoter switching
rates for Flip and Mcl1 (but accounting for their short mRNA and
protein half-life - this parameterization will later be referred as the
‘‘non-fitted’’ model) already provides a good agreement for both
Figure 1. Accounting for stochastic protein turnover in signal transduction pathways. Scheme of the modeling approach. Protein-protein
interactions mediating signal transduction (signal transduction layer) are modeled by ordinary differential equations. In parallel, promoter activity
changes, mRNA production and degradation (gene expression layer) are seen as stochastic events and generate fluctuations in mRNA levels. This
impacts the synthesis rates of the corresponding proteins. Together with protein degradation, it generates fluctuations in protein levels (here shown
in absence of transduction). Only a fragment of the extrinsic apoptosis pathway is shown. Deterministic/stochastic interpretation of chemical
reactions is represented with black/red arrows respectively.
doi:10.1371/journal.pcbi.1003893.g001
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MOMP time distribution and MOMP time correlation between
sister cells (Fig. S6). This non-trivial result shows that the speed at
which the sensitivity to TRAIL and CHX fluctuates in single cells is
well captured and thus suggests that our generic approach permits
to describe fluctuations of protein levels with sufficient accuracy.
Large, rare fluctuations of short-lived anti-apoptotic
proteins explain fractional killing and predict transient
cell fate inheritance
Spencer and colleagues repeated this experiment but treated
cells with TRAIL alone (250 ng/mL). In this condition, an
important fraction of cells died fast (MOMP in,2 hours) but 40%
were still alive after 8 hours (Fig. 3C), illustrating the fractional
killing property. Also, cell fate inheritance between sister cells was
markedly changed: only young sister cells that underwent MOMP
rapidly were importantly correlated (Fig. 4B, grey curve). We
asked whether the observed cell fate variability, including
fractional killing, could be reproduced in-silico. Within our
modeling assumptions, absence of co-treatment with CHX makes
a fundamental difference: as synthesis continues, the effect of gene
expression noise during TRAIL-induced apoptosis could be
investigated, and comparison with the TRAIL and CHX
condition is insightful. Strikingly, we found that quantitative
Figure 2. Standard stochastic protein turnover models. (A) Schematic description of the reactions constituting the stochastic protein turnover
model. Gene activity switches, mRNA production and degradation (red arrows) are stochastic reactions. Protein synthesis and degradation reactions
(black arrows) are deterministic. (B) For typical mRNA and protein half-lives, promoter switching rates have a limited influence on the protein level
half-autocorrelation time: using an analytical derivation of the protein level autocorrelation function (see Supplementary Results, Text S1), the protein
half-autocorrelation time is plotted against mean promoter switching times. (C) Behavior of a standard stochastic protein turnover model. Promoter
switching rates respect typical ranges observed by Suter et al. [36] and lead to a protein level coefficient of variation (CV) of 0.25. See Fig. S3 for more
details. Upper plots show three representative single-cell time courses of protein and mRNA levels. Histogram at the bottom displays the
corresponding distribution of protein level obtained when simulating a large number of cells for a long duration, corresponding to a snapshot of the
cell-to-cell variability expected in a population.
doi:10.1371/journal.pcbi.1003893.g002
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agreement for both MOMP time distribution and surviving
fraction could be obtained (Fig. 3F). Robustness analysis showed
that rates of the Flip and Mcl1 stochastic protein turnover model,
and particularly promoter switching rates, are in this case strongly
constrained. Interestingly, MOMP time distribution and surviving
fraction constrain those values differently (Fig. 5A–B), resulting in
an narrow ranges for their values: agreement for both observations
together is obtained only when promoter switching rates are both
low (Fig. 5C). Such low switching rates lead to large, rare
fluctuations of protein levels (Fig. 5D). Those atypical fluctuations
phenotypes are expected to leave a signature at the population
level: the shape of the protein level distribution would be bimodal
Figure 3. Cell fate variability in TRAIL-induced apoptosis. (A–C) Cell fate variability experiments performed in [13]. (A) HeLa cell populations
were treated with either 10 ng/mL of TRAIL and 2.5 mg/mL of cycloheximide (CHX) or 250 ng/mL of TRAIL alone. Cells were tracked during 8 hours by
live-cell microscopy and MOMP time was detected via mitochondrial release of a fluorescent reporter. (B–C) Histograms of MOMP times and surviving
fractions observed for treatment with (B) TRAIL and CHX or (C) TRAIL alone. (D–F) In-silico reproduction of those experiments with our ‘‘fitted’’ model
(i.e. the parameterization in the explored parameter space region giving the best agreement for cell fate variability data, described in Tables S1-3). (D)
Simulations (see Supplementary Methods in Text S1 for details). (E–F) Results for the (E) TRAIL and CHX or (F) TRAIL alone treatments. For the latter
case, representative model trajectories are given in Fig. S9.
doi:10.1371/journal.pcbi.1003893.g003
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rather than resembling a lognormal distribution (Fig. S7). This
property is thus a model prediction. Those fluctuations are likely to
impact how the fate of sister cells diverge with time. Thus, we
asked whether the model could also account for the observed fast
loss of cell fate inheritance. Remarkably, the fitted models
accurately and robustly predict MOMP time correlations between
sister cells (Figs. 4D and 5E). As mentioned earlier, the same
couple of promoter switching rates was used for Flip and Mcl1
during exploration, but further analysis showed that assuming low
promoter switching rates for Mcl1 alone was sufficient to obtain
quantitative agreement for MOMP distributions surviving frac-
tions, and that sister cells MOMP time correlations were still
correctly predicted (Fig. S8). Thus, comparison with transient cell
fate inheritance data supports that large, rare fluctuations of Mcl1
could be responsible for the observed cell fate variability.
Accounting for stochastic protein turnover predicts
reversible resistance
Recently, reversible resistance was observed among various cell
lines [14]. Cell populations were submitted to two consecutive
TRAIL treatments. The duration between treatments was varied
from 1 day to 1 week (Fig. 6A). One-day survivors were
significantly more resistant than the initial population, but such
resistance was significantly decreased or even lost in one-week
survivors. Thus, cells surviving a first TRAIL treatment are
transiently resistant. Remarkably, in-silico reproduction of those
(Fig. 6B) showed that our model predicts the presence of reversible
resistance (Fig. 6C): one-day survivors exhibit a dose-dependent
increase of resistance to a second TRAIL treatment, which
disappears after 3 to 5 days. This is surprising since our model does
not include induced regulation mediated by survival pathways.
Figure 4. Transient cell fate inheritance in TRAIL-induced apoptosis. (A–B) Experiments measuring correlation of MOMP times between
sister cells performed in [13]. (A) HeLa cells were recorded from 20 hours before treatment as in Fig. 3A. Sister cells were identified to permit
comparison of their fate. (B) Quantification of cell fate inheritance was realized by computing the correlation between sister cells MOMP time as a
function of the duration between division and MOMP (averaged between sisters). (C–D) In-silico reproduction of those experiments with the model of
Fig. 3. (C) Description. (D) Quantification of cell fate inheritance was applied to simulation results as in (B). See Supplementary Methods in Text S1 for
details.
doi:10.1371/journal.pcbi.1003893.g004
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Moreover, the presence of reversible resistance is a robust property
of the model as it is also obtained when assuming standard
promoter switching rates for Mcl1 and Flip (‘‘non-fitted’’ model,
Fig. S6). However, agreement with related experimental data
[14,15] is only qualitative. While we cannot exclude that model
parameterizations allowing a quantitative agreement exist, it might
be needed to include additional mechanisms such as survival
pathways induction to explain the observed sustained resistance
gain after one week when treating cells with a high TRAIL dose
[14].
Molecular determinants of fractional killing and
reversible resistance
What are the mechanisms behind cell escape to TRAIL-
induced apoptosis, either on the short-term (fractional killing) or
the long-term (reversible resistance)? Using the fact that in-silico,
all protein, mRNA levels and gene activity states can be monitored
in single cells, we investigated those questions at the molecular
level. To study the influence of pre-existing differences on cell fate,
we compared at the time of stimulation the sub-population of
‘future survivors’ with the whole population (Fig. 7A–B). Future
survivors strongly stood out by their Mcl1 protein level and gene
activity state (Fig. 7B). Flip also appeared to play an important role
in determining cell decision, and smaller but significant effect was
also seen for Bid, Bax, Bcl2 and XIAP. Although it is a good
predictor of cell fate, initial Mcl1 gene activity status does not
completely determine survival: neither all Mcl1 ‘‘ON’’ cells
survived nor all Mcl1 ‘‘OFF’’ cells died. Thus, pre-existing
differences in protein levels and promoter activities are major
determinant of cell fate but stochastic events in gene expression
occurring during signal transduction also play a role. While timing
of death for cells treated with TRAIL and CHX appeared to be
multi-factorial [13], our results suggest that cell survival is
predominantly determined by Mcl1 (Fig. 7B). This important role
of Mcl1 is robustly predicted. Indeed, it also holds for the ‘‘non-
fitted’’ model, which assume standard promoter switching rates for
all proteins, including Mcl1 and Flip (Fig. S6).
To investigate the determinants of reversible resistance, we
tracked the temporal evolution of protein levels in surviving cells
(Fig. 7 A&C). The protein level composition of one day survivors
contrasts with the protein content observed in future survivors:
almost all protein levels differ importantly from the naı¨ve
population composition, while that was the case only for Mcl1
and Flip in future survivors. This is expected as all proteins are
partly activated during signal transduction, leading to a higher
degradation (active forms have a shorter half-life). Therefore, the
distinction between the causes of cell survival and the conse-
quences of partial apoptosis induction cannot be easily resolved by
the sole observation of protein levels in survivors. When signaling
stops, recovery of protein levels is expected to follow exponential
kinetics governed by the turnover rate (Fig. 7C, inset – see the
death receptor (R), pro-caspase 8, Bar and Bid). Deviation from
such kinetics indicates either the persistence of signaling reactions
that continue to consume proteins (it is the case for Apaf, pro-
caspase 9 and XIAP, as further analysis confirmed) or is a
consequence of important selection. Indeed, while Mcl1 and Flip
Figure 5. Model fitting to cell fate variability data predicts large, rare fluctuations of Flip/Mcl1 and transient cell fate inheritance.
(A–C) Agreement between model prediction and experimental data for (A) death (i.e. MOMP) time distribution, (B) surviving fraction after 8 hours,
and (C) both together, for treatment by TRAIL alone (250 ng/mL), as a function of Flip/Mcl1 promoter switching times (other parameters as in Table
S1). (D) Representative protein level fluctuations of Mcl1 described by a stochastic protein turnover model allowing good agreement for both MOMP
time distribution and surviving fraction. This model has been used for Figs. 3,4,6 and 7. (E) Model-data agreement for MOMP time correlation
between sister cells. For (A), (B), (C) and (E), agreement quality increases from red to green. The quantification algorithm is detailed in Supplementary
Methods (Text S1).
doi:10.1371/journal.pcbi.1003893.g005
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should recover normal levels in a few hours in absence of selection
because of their high turnover rate, Mcl1 levels (but not Flip levels)
are still strongly higher than in naive cells one day after TRAIL
treatment, consistently with previous observations on the relative
selection strength that operated on them. Together, those results
indicate that recovery phenotypes in surviving cells result from a
complex interplay of three distinct effects: selection during
apoptosis, transcriptional noise and protein turnover as a driving
force tending to reset protein levels to their initial, pre-stimulus
distribution, and long-term residual signaling activity. This
explains why it is difficult to understand the recovery process
and justifies the use of modeling to disentangle the various
contributions.
Discussion
Rehm et al. and Spencer et al. [13,20] made two insightful
observations about TRAIL-induced apoptosis. First, recently born
sister cells died almost synchronously when treated with TRAIL
and a protein synthesis inhibitor, while in contrast, unrelated cells
died after highly variable durations. This demonstrated that
TRAIL signaling is mostly deterministic when protein synthesis is
blocked and that the timing of death is determined by the cell
internal state at the time of treatment. Second, they observed that
such synchrony in sister cells death is gradually lost as the time
between division and treatment increases. This showed that the
cell ’TRAIL sensitivity state’ (the part of cell internal state involved
in death timing determination) naturally fluctuates over a dozen of
hours. In addition, the modeling results in ref. [13] highly
suggested that such state is mainly composed by the various levels
of the proteins acting in the extrinsic apoptosis pathway. In
parallel, important progress on the characterization of the
stochasticity in gene expression has been made: the two-state
transcriptional bursting model was shown to permit high accuracy
and several approaches to infer its parameters were proposed,
enabling the quantitative modeling of protein fluctuations in single
cells [34–40].
Modeling protein fluctuations in TRAIL-induced
apoptosis
In this study, we merged those two approaches by integrating
such stochastic models of gene expression within an existing kinetic
model of TRAIL-induced apoptosis [5] in a systematic and
principled manner. Doing so provides advantages compared to
previous approaches to account for cell-to-cell variability in
protein levels [13,25]. First, variability is not considered as an
‘‘input’’ parameter but arises naturally from stochastic fluctua-
tions. The dynamics of this variability is thus intrinsically
represented within the system, allowing investigating the effects
Figure 6. Reversible resistance in repeated TRAIL treatments. (A) Schematic description of the ‘repeated TRAIL’ experiments performed in
[14,15] to characterize reversible resistance in HeLa cells. (B) In-silico reproduction of these experiments with our model (details in Supplementary
Methods, Text S1). (C) Resistance gains in surviving cells relative to naı¨ve cells as a function of time between the two TRAIL treatments. Data are
shown for experimental observations [14,15] and model predictions (our study). Comparison of resistance gain experimental measurements between
the two TRAIL doses (500 and 50 ng/mL for [14] and [15] respectively) should be done with care, as the measurement and quantification method
differed.
doi:10.1371/journal.pcbi.1003893.g006
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of transient memory in protein levels. Second, the influence of
protein synthesis noise during TRAIL-induced apoptosis could
also be investigated. Importantly, we followed a parsimonious
parameterization strategy, motivated by the fact that fluctuations
of long-lived proteins are rather insensitive to the precise kinetics
of transcriptional bursting, enabling us to equip most proteins
(long-lived proteins) with reasonably accurate fluctuation models
even in absence of gene expression data for each and every
promoter. The sister cells experiment for which cells were treated
with TRAIL and CHX provided ideal data to validate our
modeling approach: in that case, behavior is mostly deterministic
as soon as treatment starts and only fluctuations occurring before
treatment are responsible for death time variability and de-
correlation between sister cells. Moreover, gene regulation via
survival pathways induction is ineffective as protein synthesis is
blocked. Because our model was able to quantitatively reproduce
the MOMP time distribution and then accurately predicted sister
cells correlation, our modeling approach appears as a promising
tool to investigate the effect of protein fluctuations on signal
transduction, despite the limitations inherent to its simplicity (for
Figure 7. Molecular determinants of cell fate and resistance to repeated TRAIL treatments. (A) Cartoon illustrating that the determinants
of cell fate and resistance can be studied by analyzing the over-representation of protein levels in ‘future survivors’ (cells that will still be alive after
treatment) at the time of treatment, and in surviving cells at day X, respectively. (B) Cell fate determinants analysis: over-representation (compared to
initial population) of protein level (blue) and promoter activity (red) at the time of treatment in ‘future survivors’. Asterisks mark differences that
passed a 5% significance test. (C) Resistance determinants analysis: over-representation of protein levels in surviving cells at day X. Inset illustrates the
recovery kinetics expected from protein turnover only (i.e. in absence of significant selection effect or residual signaling activity). Therefore, deviation
from such kinetics indicates the presence of a selection effect or residual signaling activity.
doi:10.1371/journal.pcbi.1003893.g007
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example, stochastic gene expression events were assumed to be
independent between proteins, neglecting the fact that levels of
different proteins can be partially correlated [25,26], possibly
because of common transcription factors or coordinated chroma-
tin-state transitions). Of note, good agreement was readily
obtained when assuming for Flip and Mcl1 standard promoter
switching rates, but short protein and mRNA half-lives - in
agreement with available knowledge (‘‘non-fitted’’ model, Fig. S6).
Finally, the transposition of fluctuation timescales from individual
proteins into ‘TRAIL sensitivity states’ is not trivial: while in our
model, stable proteins levels are mixed in about 40 hours, cells
were switching between ’fast dying’ and ’slow dying’ phenotypes
more rapidly (about 10–15 hours). As combinatorial effects are at
play, mechanistic models of protein-proteins reactions are needed
to link protein-level timescales with more high-level phenotypic
transitions [45].
Questioning the role of survival pathways
Several studies reported that TRAIL can induce survival
pathways [17–19]. How such induced changes affect signal
transduction and eventually stop apoptotic signaling remains
unclear. On the other hand, the contribution of constitutive
protein synthesis noise, which is responsible for pre-existing
differences between cells, has not been evaluated. Although it
does not exclude the existence of other mechanisms, an important
result of our study is that fractional killing can be obtained without
assuming any TRAIL-induced regulation. Alternatively, we find
that because of its fast turnover, constitutive expression of the
Mcl1 protein has the potential to rescue cells from TRAIL
apoptotic signaling. In this context, solely accounting for protein
fluctuations within the TRAIL apoptosis pathway predicts the
fractional killing property (Figs. 3 and S6). While our results
challenge current opinion on the role of survival pathways in
TRAIL-induced apoptosis, they are consistent with observations
made on wild type HeLa cells that neither blocking NF-kB
response nor inhibiting the Akt pathway do significantly change
the surviving cell fraction after TRAIL treatment [46,47]. The
pivotal role for Mcl1 in TRAIL-induced apoptosis predicted by
our model is consistent with the recent finding that Mcl1 silencing
by shRNA in HeLa cells completely sensitize cells to TRAIL [48].
While moderate fluctuations of Mcl1 levels were sufficient to
obtain fractional killing, a quantitative agreement with the
Spencer et al. [13] single-cell data (MOMP time distribution
and surviving fraction) required large and rare Mcl1 fluctuations,
caused by rare switches between long periods of gene activity or
inactivity. Interestingly, in that case, the observed rapid loss of
MOMP time correlation between sister cells quantitatively
emerged from model simulations. Flip is often mentioned as a
key factor in cell resistance to TRAIL [49], but in our model Flip
has less impact on cell survival than Mcl1. Consistently, Lemke et
al. [48] silencing experiments demonstrated a dominant role for
Mcl1 and a synergy with Flip. However, our model might under-
estimate the role of Flip: the representation of DISC-related events
in EARM is simple and thus does not account for recent biological
findings, including the stoichiometry between its components
[50,51]. Improving how DISC assembly is modeled might thus be
needed to elucidate the precise role of Flip in fractional killing and
reversible resistance, especially for cell lines that express higher
Flip amounts than HeLa.
Origins of reversible resistance: joint effect of selection
and stochastic protein turnover
A second significant result reported here is that our model
predicts the phenomenon of reversible resistance, showing that
constitutively noisy protein synthesis, protein-protein interactions
and protein degradation are by themselves sufficient to explain a
dose-dependent, significant increase of resistance in recent
survivors and its gradual loss within 3–5 days. This result is
consistent with the observation that Nf-kB blockade does not
change resistance acquisition after TRAIL treatment [14] (in
MCF10A cells; HeLa cells have not been tested). In-silico analysis
at the molecular level revealed that reversible resistance as
predicted by the model was shaped by a complex interplay
between 1) selection based on protein levels and transcriptional
activity, 2) protein turnover and 3) residual signaling activity. As
opposed to the death process, which involves a sharp and complete
activation of effector caspases, our results suggest that recovery in
cells that did not commit to death is a slow and complex process.
While one should not conclude from our results that parallel
activation of survival pathways by TRAIL plays no role in
reversible resistance, our results show that the sole contribution of
protein level fluctuations occurring within the extrinsic apoptosis
pathway can partly lead to reversible resistance. Thus, protein
fluctuations should be accounted for to gain quantitative insights
into reversible resistance.
Accounting for gene expression noise appears necessary
to investigate signal transduction
While here we focused on TRAIL-induced apoptosis, our
modeling approach is generic and can be applied to other signal
transduction pathways. Our results showed that even in absence of
induced gene regulation, gene expression noise interacts with
signaling dynamics on a non-trivial manner. Thus, even in
contexts where the influence of induced gene-regulation is
indisputable, its sound quantification probably requires to
investigate first the role of constitutive gene expression noise.
Only then models could be enriched parsimoniously with well-
characterized regulatory links until all observations are successfully
explained. Significant advances to allow such detailed character-
ization of gene regulation occurred recently [31,52,53]. Following
such approaches could significantly extend the reach of models of
signal transduction towards accurate, single-cell level description
of populations submitted to varying signaling contexts over
multiple cell generations.
Methods
Modeling stochastic protein turnover
Denoting Gon and Goff the two states of the promoter, m the
number of mRNAs and P the protein level, the stochastic protein
turnover model comprises the following reactions:
Gon
koff
Goff , Goff
kon
Gon (Gene activity switches).
Gon
ksm
Gonzm , m
cm 1 (Transcription and
mRNA degradation).
m
ksp
mzP , P
cp
1 (Translation and protein deg-
radation).
We interpret the four first reactions as stochastic reactions and
the translation and protein degradation reactions as deterministic
reactions. Thus, the model state is given by a Boolean
G~Gon~1{Goff , an integer m and a continuous variable P.
The statistical properties of this system can be investigated
analytically by writing the corresponding chemical master
equation, which describes the temporal evolution of the state joint
probability distribution. While the obtained equations cannot be
solved analytically, it can be used to derive moments of the
underlying distribution by applying generating functions tech-
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niques, as was done by Paszek [39]. We next give the analytical
expressions of several moments of interest:
E G½ ~ kon
konzkoff
~
kon
cg
cg~konzkoff
 
CV G½ 2~ 1{E G½ 
E G½ 
E m½ ~E G½  ksm
cm
, CV m½ 2~ cm
cmzcg
CV G½ 2z 1
E m½ 
E P½ ~E m½  ksp
cp
, CV P½ 2~ cpcm cpzcmzcg
 
cmzcp
 
cmzcg
 
cpzcg
 
CV G½ 2z cp
cmzcp
1
E m½ 
While those expressions characterize the steady-state distribu-
tion of the model, and thus can be compared to snapshot
measurements of a cell population, they do not provide
information about how fast single cells move with time within
those distributions. Such information can be obtained by
computing the autocorrelation function. Its expression and
derivation are given in Supplementary Results (Text S1).
Modeling TRAIL-induced apoptosis and protein
fluctuations
We used the EARM model described in Spencer et al. [13] to
represent protein-protein reactions. No kinetic rates were changed,
except the rate of pC6 cleavage by C3, set to zero to remove the
feedback loop. Degradation rates of non-native forms were
modified according to biological knowledge (Table S3). The effect
of those changes is discussed in SI Appendix. Rates of the standard
stochastic protein turnover models and rates of Flip&Mcl1 models
were determined following an algorithm constructed to incorpo-
rate constraints based on biological knowledge (Fig. S4). Their
values are given in Table S1-2. Notably, for comparability and
consistency with the findings of Spencer et al. [13], we kept their
mean protein values, even if for a few proteins new data were
available, as for Mcl1 for example [54], provided that the order of
magnitude is the same.
In-silico ‘‘sister cells’’ and ‘‘repeated TRAIL’’ experiments
The simulation procedure is detailed in SI Appendix. Briefly,
mother cell states (promoter activity, mRNA and protein levels)
were chosen by Monte-Carlo sampling and the two sister cells
were constructed by duplication of the mother cell state. Promoter
activity and mRNA fluctuations were simulated using an
implementation of the Gillespie algorithm. For the ODEs
governing evolution of all protein levels, the Semi-Implicit
Extrapolation method was used. MOMP was considered to have
occurred when half of mitochondrial Smac has been released. For
all simulations, at least 104 pairs of sister cells were simulated.
Quantitative comparison of simulation results with related
experimental data (Fig. 5) was achieved by computing a measure
of model-data agreement described in Supplementary Methods
(Text S1). For repeated TRAIL simulations, a naı¨ve population of
104 cells was obtained as in the sister cells experiment. Cells
divided after a gaussian cell cycle duration (mean 27 hours,
standard deviation 3 hours). Death was detected via cPARP levels
as in Gaudet et al. [25].
Supporting Information
Figure S1 Simplified view of the TRAIL-induced apop-
tosis pathway. Only the type of each protein-protein interaction
(activation or inhibition) is represented. A diagram displaying the
detail of protein complexes and activated forms can be find in [5].
(PDF)
Figure S2 Numerical simulation and analytical charac-
terization of stochastic protein turnover models. A
stochastic protein turnover model is defined by six rates: the
promoter activity switching rates, the mRNA production and
degradation rates, the protein per mRNA synthesis rate and the
protein degradation rate. Numerical simulations can be used to
simulate temporal fluctuations in single cells. When a population
of cells is simulated, the cell-to-cell variability can be studied. After
some time, cell-to-cell variability reaches a steady state. Analytical
calculations on the stochastic protein turnover model provide
expressions characterizing the steady-state variability (moments of
the steady-state distributions), but also fluctuations (autocorrelation
functions). Complete expressions are given in Text S1.
(PDF)
Figure S3 Fluctuations of protein levels caused by
transcriptional bursting are smoothed out for long-lived
proteins. Comparison of protein level coefficient of variation (A)
and half-autocorrelation time (C) as a function of transcriptional
bursting rates for two situations: a short-lived protein and mRNA
(half-lives of 2 and 1 hours, resp.) and a long-lived protein and
mRNA (27 and 9 hours, resp.). Other rates of the stochastic
protein turnover model are chosen such that mean protein and
mRNA level are the same (1000 and 17). Combinations of Ton
and Toff values ranging from 0.1 to 5 hours and 0.1 to 10 hours
respectively were tested. Ton and Toff are mean ON and OFF
time of the gene. (B and D) Representation of the range of values
obtained for all models tested in (A) and (C).
(PDF)
Figure S4 Building stochastic protein turnover models
for TRAIL-induced apoptosis. Routine followed to choose
rates of all 17 native proteins in the EARM kinetic model of
TRAIL-induced apoptosis. Typical values from multi-genes
studies in mammalian cells are used to constrain rate values.
Specific attention is given to Flip and Mcl1 because they are
known to be short-lived, and thus more prone to exhibit large
variations.
(PDF)
Figure S5 Stochastic protein turnover models captures
fluctuations of cell sensitivity to TRAIL and CHX. (A) Best
found agreement between model and data for MOMP times
distribution in the +CHX condition. Obtained for Flip and Mcl1
model rates such that protein/mRNA half-life and mean ON/
OFF promoter activity duration equaled 0.4/1 and 1.9/3.1 hours
respectively. See Supplementary Methods (Text S1) for quantifi-
cation of model data agreement. (B) Best found agreement
between model and data for MOMP time correlation between
sisters in the +CHX condition. Obtained for Flip and Mcl1 model
rates such that protein/mRNA half-life and mean ON/OFF
promoter activity duration equaled 0.3/1 and 0.35/24 hours
respectively. (C) Influence of Flip and Mcl1 model rates on Model-
Data agreement in the +CHX condition. For each parameter, we
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plot the model to data distance corresponding to the best model
when all other three parameters are varied.
(PDF)
Figure S6 The ‘‘non-fitted’’ model quantitatively pre-
dicts TRAIL+CHX single-cell data and lead to fractional
killing and reversible resistance for TRAIL alone treat-
ments. In the non-fitted model, Flip and Mcl1 promoter switching
rates are standard (Ton = 0.1 hours and Toff = 2.6 hours) but the
short-half life of their mRNA and protein is accounted for (2 hours
and 0.5 hours respectively). We reproduce here for this model all
the results presented in the main text for the ‘‘fitted’’ model.
Quantitative agreement is obtained for TRAIL + CHX single cell
data from Spencer et al. [13] (MOMP time distribution and sister
cell MOMP time correlations). No quantitative agreement is
obtained in the case of TRAIL alone treatments, but the existence
of fractional killing and reversible resistance is nevertheless
predicted. Note that because fewer cells were simulated compared
to main text figures (50000 instead of 105 for sister cell experiments),
sister correlation curves appears slightly noisier.
(PDF)
Figure S7 Mcl1 and Flip fluctuations for standard or
‘‘fitted’’ promoter switching rates. For the top frame,
promoter switching rates are standard (as in Fig. 2). Because
mRNA and protein half-lives are short, protein level fluctuates more
rapidly and the steady-state distribution is changed (it is wider and
the mode is in 0) compared to the standard stochastic protein
turnover model (Fig. 2). On the bottom frame, the steady-state
distribution becomes bimodal because the promoter switching rates
are low compared to mRNA and protein degradation. In both
cases, fluctuations and distribution are shown for Mcl1; they are
similar for Flip as only the protein synthesis rate changes to account
for a different mean protein level.
(PDF)
Figure S8 Large, rare fluctuations of Mcl1 alone are
sufficient to explain cell fate variability and transient
inheritance in both conditions. While Flip and Mcl1 protein
and mRNA half-lives were the same as for the ‘‘fitted’’ model (0.4
and 1.0 hours respectively), only the Mcl1 promoter was assumed
to have low switching rates (Ton and Toff are 16 and 24 hours
resp.). The switching rates of the Flip promoter were assumed to
be standard (Ton = 0.1 hours and Toff = 2.6 hours). All the
results presented in the main text for the ‘‘fitted’’ model are
reproduced here. Note that because fewer cells were simulated
compared to main text figures (50000 instead of 105 for sister cell
experiments), sister correlation curves appears slightly noisier.
(PDF)
Figure S9 Representative single-cell trajectories before
and after TRAIL treatment for the ‘‘fitted’’ model.
Trajectories for two dying and two surviving cells (after 12 hours
of TRAIL treatment) are shown. T-marked arrows denote the
time of TRAIL addition (250 ng/mL), D-marked arrows denote
the time of death commitment (MOMP). mRNA (lower left of
each panel) and native form protein levels (upper left of each
panel) are shown for pro-caspase 8, Bid and Mcl1. Levels of
activated caspase 8, truncated Bid and activated caspase 3 are also
shown (upper right of each panel), as well as the ratio of released
Smac and of cleaved PARP (lower right of each panel).
(PDF)
Figure S10 Robustness of short-term model behavior
regarding the presence/absence of feedback loop and
the degradation of active forms. Model-Data agreement is
shown for MOMP time distributions, surviving fractions and
sisters correlation of MOMP time in both treatment conditions for
model variants when the C3-.C6-.C8 feedback loop is either
present/absent and the default active forms half-life is 27, 15, 5 or
2 hours. Significant model-data deviation is seen only for the
fastest active forms degradation.
(PDF)
Figure S11 Resistance gain in one day survivors is
robust regarding the presence/absence of feedback loop
and the degradation of active forms. In-silico repeated
TRAIL experiment (as in Fig. 6) was repeated for variants of the
‘‘fitted’’ model regarding presence/absence of the C3-.C6-.C8
feedback loop and the default active forms half-life. Resistance
gain in one-day survivors is shown. Simulations were repeated 4
times with 104 cells, error bars indicate standard deviation of
estimated resistance gain between replicates.
(PDF)
Figure S12 Long-term population survival is not possi-
ble with the feedback loop and stable active forms.
Evolution of alive cell number in populations treated in-silico as in
Fig. 6, for model several variants regarding presence/absence of
the C3-.C6-.C8 feedback loop and the default active forms half-
life.
(PDF)
Table S1 Standard stochastic protein turnover models.
(DOCX)
Table S2 Specific stochastic protein turnover models.
(DOCX)
Table S3 Non-native form degradation.
(DOCX)
Text S1 Supplementary results and supplementary
methods.
(DOCX)
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